Cargando…
Practical combination therapy based on pathophysiology of type 2 diabetes
Type 2 diabetes is a complex, chronic, and progressive condition that often necessitates the use of multiple medications to achieve glycemic goals. Clinical guidelines generally recommend intensifying pharmacotherapy if glycemic goals are not achieved after 3 months of treatment. However, for many p...
Autor principal: | Levin, Philip A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096777/ https://www.ncbi.nlm.nih.gov/pubmed/27826204 http://dx.doi.org/10.2147/DMSO.S109216 |
Ejemplares similares
-
Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment
por: Triplitt, Curtis, et al.
Publicado: (2010) -
Type 2 diabetes and remission: practical management guided by pathophysiology
por: Taylor, Roy
Publicado: (2020) -
Pathophysiology of Type 2 Diabetes Mellitus
por: Galicia-Garcia, Unai, et al.
Publicado: (2020) -
Pathophysiology of Type 2 Diabetes in Koreans
por: Kwak, Soo Heon, et al.
Publicado: (2018) -
Role of gut microbiota in type 2 diabetes pathophysiology
por: Gurung, Manoj, et al.
Publicado: (2020)